Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AZN | AMGN | GILD | BMY |
| Company | Clovis Oncology Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0808 | 198.85 | 350.23 | 136.18 | 59.15 |
| High | 0.0977 | 198.99 | 350.23 | 136.34 | 59.73 |
| Low | 0.0766 | 195.77 | 340.06 | 132.22 | 57.79 |
| Latest | 0.0812 | 195.78 | 344.86 | 133.29 | 59.39 |
| Change | -0.0048 | -4.91 | -5.30 | -2.58 | +0.26 |
| % Change | -5.58% | -2.45% | -1.51% | -1.90% | +0.44% |
| Volume | 24,516,400 | 2,130,700 | 2,066,800 | 6,070,500 | 9,002,300 |
| 20-Day Average Volume | 9,433,500 | 1,869,935 | 2,448,250 | 5,247,570 | 9,851,400 |
| Previous Close | 0.0860 | 200.69 | 350.16 | 135.87 | 59.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 198.33 | 349.70 | 138.47 | 59.10 |
| 20-Day Raw Stochastic | 1.73% | 53.75% | 40.19% | 9.95% | 50.91% |
| 20-Day Relative Strength | 23.83 | 48.46 | 44.04 | 39.03 | 51.44 |
| Weighted Alpha | -91.19 | +38.36 | +21.28 | +25.18 | +28.10 |
| Today's Opinion | 100% Sell | 64% Buy | 24% Buy | 24% Buy | 64% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | -4.21% since 04/14/26 | -1.74% since 04/14/26 | -5.10% since 04/14/26 | +2.26% since 04/14/26 |
| Low | 0.0760 on 12/16/22 | 195.77 on 04/21/26 | 340.06 on 04/21/26 | 132.22 on 04/21/26 | 57.22 on 04/15/26 |
| High | 0.1439 on 12/14/22 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | +6.63% since 03/20/26 | -0.85% since 03/20/26 | -2.86% since 03/20/26 | +3.32% since 03/20/26 |
| Low | 0.0760 on 12/16/22 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 132.22 on 04/21/26 | 56.45 on 03/24/26 |
| High | 0.3772 on 12/01/22 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | +8.12% since 01/21/26 | +0.37% since 01/21/26 | +3.24% since 01/21/26 | +8.97% since 01/21/26 |
| Low | 0.0760 on 12/16/22 | 180.34 on 01/22/26 | 335.06 on 04/07/26 | 129.00 on 01/22/26 | 54.21 on 01/29/26 |
| High | 1.3100 on 10/04/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | +17.63% since 10/21/25 | +14.52% since 10/21/25 | +7.42% since 10/21/25 | +33.34% since 10/21/25 |
| Low | 0.0760 on 12/16/22 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 3.2500 on 07/08/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 311,251,712 | 188,976,096 | 168,644,832 | 120,727,792 |
| Shares Outstanding, K | 144,955 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 148,760,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -264,520,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 30,660,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -56,010,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.24 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/22/23 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.36 | 16.26 | 16.89 | 9.78 |